Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Treasury Shares (2016 - 2022)

Historic Treasury Shares for Aptevo Therapeutics (APVO) over the last 7 years, with Q4 2022 value amounting to $223775.0.

  • Aptevo Therapeutics' Treasury Shares rose 29390.07% to $223775.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $223775.0, marking a year-over-year increase of 29390.07%. This contributed to the annual value of $223775.0 for FY2022, which is 29390.07% up from last year.
  • Aptevo Therapeutics' Treasury Shares amounted to $223775.0 in Q4 2022, which was up 29390.07% from $56810.0 recorded in Q4 2021.
  • In the past 5 years, Aptevo Therapeutics' Treasury Shares ranged from a high of $223775.0 in Q4 2022 and a low of $9000.0 during Q4 2020
  • In the last 5 years, Aptevo Therapeutics' Treasury Shares had a median value of $61771.0 in 2021 and averaged $77121.5.
  • As far as peak fluctuations go, Aptevo Therapeutics' Treasury Shares crashed by 9510.53% in 2019, and later skyrocketed by 53122.22% in 2021.
  • Quarter analysis of 5 years shows Aptevo Therapeutics' Treasury Shares stood at $133040.0 in 2018, then tumbled by 86.88% to $17458.0 in 2019, then crashed by 48.45% to $9000.0 in 2020, then surged by 531.22% to $56810.0 in 2021, then surged by 293.9% to $223775.0 in 2022.
  • Its Treasury Shares stands at $223775.0 for Q4 2022, versus $56810.0 for Q4 2021 and $63951.0 for Q3 2021.